Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

82
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
82
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

861
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
861
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

548
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
548
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

331
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
331
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

5.6K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

426
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
426

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomic profiling in pediatric food allergy: Toward biomarkers for disease characterization and treatment response.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias.

International journal of molecular sciences·2026
Same author

Metabolomics for Preclinical Detection of Diabetic Kidney Disease: A Comprehensive Review.

International journal of molecular sciences·2026
Same author

Lipid Profile and Management of Dyslipidemias in Pregnancy.

Journal of cardiovascular development and disease·2025
Same author

Combination of triglyceride-glucose index and waist-to-height ratio as a predictor of all-cause and cardiovascular mortality in adults with diabetes or prediabetes: a nationwide prospective cohort study.

Cardiovascular diagnosis and therapy·2025
Same author

Altered HDL Phospholipid and Fatty Acid Profile in MASLD: A Possible Explanation for the Increased CVD Risk.

International journal of molecular sciences·2025
Same journal

LncRNA signature associated with amino acid metabolism: A novel prognostic tool for Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.

Current medicinal chemistry·2026
Same journal

EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.

Current medicinal chemistry·2026
Same journal

DHRS2 as a Novel Thalidomide Target Regulating Mitophagy and Inflammation in Head and Neck Squamous Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

Synthetic AtMP2 from Anabas testudineus: Comprehensive ADMET and In Vivo Toxicity Assessment to Enable Future Therapeutic Development.

Current medicinal chemistry·2026
Same journal

Screening of Medicinal and Edible Homology Substances for Diabetic Kidney Disease Based on GraphBAN.

Current medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Oct 28, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.5K

Environmental Factors Modifying HDL Functionality.

Constantine E Kosmas1, Andreas Sourlas2, Eliscer Guzman1

  • 1Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.

Current Medicinal Chemistry
|July 16, 2021
PubMed
Summary
This summary is machine-generated.

High-Density Lipoprotein (HDL) functionality, not just cholesterol levels, is key for cardiovascular health. Environmental factors significantly impact HDL function, influencing cholesterol efflux capacity and cardiovascular risk.

Keywords:
HDL functionalityaerobic exercisealcoholcholesterol efflux capacity (CEC)dietary habitsobesitypharmacologic interventionssmoking

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.8K

Related Experiment Videos

Last Updated: Oct 28, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.8K

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • High-Density Lipoprotein (HDL) functionality, particularly cholesterol efflux capacity (CEC), is more critical for atherosclerosis protection than HDL cholesterol (HDL-C) levels.
  • HDL's cardioprotective effects extend beyond reverse cholesterol transport to include anti-inflammatory and antioxidant properties.
  • Various factors, including genetics, disease, and environment, can alter HDL composition and function.

Purpose of the Study:

  • To review the impact of environmental factors on High-Density Lipoprotein (HDL) functionality.
  • To explore how lifestyle choices and interventions influence HDL's role in cardiovascular health.
  • To highlight the importance of assessing HDL functionality for cardiovascular disease (CVD) risk evaluation.

Main Methods:

  • Review of experimental and clinical studies.
  • Analysis of the effects of environmental factors such as obesity, smoking, alcohol, diet, and exercise.
  • Examination of various pharmacologic interventions impacting HDL functionality.

Main Results:

  • Environmental factors demonstrably modify HDL functionality.
  • Pharmacologic interventions and healthy habits can positively influence HDL function.
  • The precise mechanisms by which these factors affect HDL functionality require further elucidation.

Conclusions:

  • Understanding the mechanisms linking environmental factors to HDL function is crucial.
  • Further research is needed to develop interventions that enhance CEC and improve HDL functionality.
  • Enhancing HDL functionality holds potential for reducing cardiovascular risk.